The effects of pneumopericardium during epicardial catheter ablation after dry pericardiocentesis on patients with ventricular arrhythmia.
Epicardial catheter ablation
Pericardiocentesis
Pneumopericardium
Prognosis
Ventricular arrhythmia
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
01
05
2022
accepted:
28
07
2022
pubmed:
2
8
2022
medline:
4
3
2023
entrez:
1
8
2022
Statut:
ppublish
Résumé
Pneumopericardium is a rare complication of epicardial ablation after dry pericardiocentesis to treat ventricular arrhythmia (VA); its exact clinical effects on patients are still unclear. The purpose of this study was to evaluate the clinical effects of pneumopericardium during epicardial ablation on patients with VA. Patients with VA who underwent epicardial catheter ablation under local anesthesia at West China Hospital of Sichuan University from August 2012 to January 2022 were enrolled in this study. The incidence of pneumopericardium was investigated. The occurrence of major adverse cardiovascular events (MACEs) was evaluated 1 year after the operation. A total of 86 VA patients were included in the study. Twenty-two cases had pneumopericardium, with an incidence rate of 25.6%, and 12 (54.55%) patients complained of dyspnea during the procedure with an average occurrence time of 5.4 ± 3.2 min after pericardiocentesis. The blood pressure (BP) decreased significantly, with the mean BP dropping from 119.8/73.2 to 103.5/64.9 mmHg (p < 0.001). None of the cases progressed to tension pneumopericardium. Postoperative follow-up with a median period of 411 days showed that the incidence rate of major adverse cardiovascular events (MACEs), including the composite endpoints of all-cause death, rehospitalization for heart failure, and tachyarrhythmia events, was 36.4% (n = 8) in the pneumopericardium group and 35.5% (n = 23) in the non-pneumopericardium group. The Kaplan-Meier survival analysis showed that there was no statistically significant difference in the incidence of MACEs between the two groups (p = 0.28). The incidence of pneumopericardium during epicardial ablation was relatively high. However, if recognized early and managed properly, it is unlikely to progress to tension pneumopericardium. The occurrence of pneumopericardium during the procedure may not significantly affect the long-term prognosis of patients.
Sections du résumé
BACKGROUND
BACKGROUND
Pneumopericardium is a rare complication of epicardial ablation after dry pericardiocentesis to treat ventricular arrhythmia (VA); its exact clinical effects on patients are still unclear. The purpose of this study was to evaluate the clinical effects of pneumopericardium during epicardial ablation on patients with VA.
METHODS
METHODS
Patients with VA who underwent epicardial catheter ablation under local anesthesia at West China Hospital of Sichuan University from August 2012 to January 2022 were enrolled in this study. The incidence of pneumopericardium was investigated. The occurrence of major adverse cardiovascular events (MACEs) was evaluated 1 year after the operation.
RESULTS
RESULTS
A total of 86 VA patients were included in the study. Twenty-two cases had pneumopericardium, with an incidence rate of 25.6%, and 12 (54.55%) patients complained of dyspnea during the procedure with an average occurrence time of 5.4 ± 3.2 min after pericardiocentesis. The blood pressure (BP) decreased significantly, with the mean BP dropping from 119.8/73.2 to 103.5/64.9 mmHg (p < 0.001). None of the cases progressed to tension pneumopericardium. Postoperative follow-up with a median period of 411 days showed that the incidence rate of major adverse cardiovascular events (MACEs), including the composite endpoints of all-cause death, rehospitalization for heart failure, and tachyarrhythmia events, was 36.4% (n = 8) in the pneumopericardium group and 35.5% (n = 23) in the non-pneumopericardium group. The Kaplan-Meier survival analysis showed that there was no statistically significant difference in the incidence of MACEs between the two groups (p = 0.28).
CONCLUSIONS
CONCLUSIONS
The incidence of pneumopericardium during epicardial ablation was relatively high. However, if recognized early and managed properly, it is unlikely to progress to tension pneumopericardium. The occurrence of pneumopericardium during the procedure may not significantly affect the long-term prognosis of patients.
Identifiants
pubmed: 35915196
doi: 10.1007/s10840-022-01327-5
pii: 10.1007/s10840-022-01327-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
373-379Subventions
Organisme : the Study on Accurate Diagnosis and Treatment of Atrial Fibrillation
ID : JH2018040
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Sosa E, Scanavacca M, d’Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7(6):531–6.
doi: 10.1111/j.1540-8167.1996.tb00559.x
pubmed: 8743758
Sacher F, Roberts-Thomson K, Maury P, Tedrow U, Nault I, Steven D, et al. Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol. 2010;55(21):2366–72.
doi: 10.1016/j.jacc.2009.10.084
pubmed: 20488308
Shah H, Salahudin M, Altaf A. Asymptomatic pneumopericardium with atrial fibrillation after pericardiocentesis: a case report. J Tehran Heart Cent. 2019;14(3):134–7.
pubmed: 31998390
pmcid: 6981340
Bonardi CM, Spadini S, Fazio PC, Galiazzo M, Voltan E, Coscini N, et al. Nontraumatic tension pneumopericardium in nonventilated pediatric patients: a review. J Card Surg. 2019;34(9):829–36.
doi: 10.1111/jocs.14159
pubmed: 31269314
Tung R, Shivkumar K. Epicardial ablation of ventricular tachycardia. Methodist Debakey Cardiovasc J. 2015;11(2):129–34.
doi: 10.14797/mdcj-11-2-129
pubmed: 26306131
pmcid: 4547668
Guandalini GS, Liang JJ, Marchlinski FE. Ventricular tachycardia ablation: past, present, and future perspectives. JACC Clin Electrophysiol. 2019;5(12):1363–83.
doi: 10.1016/j.jacep.2019.09.015
pubmed: 31857035
Kim YH, Chen SA, Ernst S, Guzman CE, Han S, Kalarus Z, et al. 2019 aphrs expert consensus statement on three-dimensional mapping systems for tachycardia developed in collaboration with hrs, ehra, and lahrs. J Arrhythm. 2020;36(2):215–70.
doi: 10.1002/joa3.12308
pubmed: 32256872
pmcid: 7132207
Shen LS, Liu LM, Zheng LH, Hu F, Hu ZC, Liu SY, et al. Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. J Geriatr Cardiol. 2020;17(11):694–703.
pubmed: 33343648
pmcid: 7729178
Matos D, Adragão P, Pisani C, Hatanaka V, Freitas P, Costa F, et al. Outcomes of a combined vs non-combinedendo-epicardial ventricular tachycardia ablation strategy. J Interv Card Electrophysiol. 2022. https://doi.org/10.1007/s10840-022-01175-3 .
Ju W, Zhang J, Shi L, Gu K, Chu M, Chen H, et al. Epicardial catheter ablation of idiopathic ventricular arrhythmias originating from uncommon epicardial sites. J Interv Card Electrophysiol. 2022 May 23. https://doi.org/10.1007/s10840-022-01149-5 .
Cardoso R, Aryana A, Singh SM, Tandri H, d’Avila A. Epicardial ablation of ventricular tachycardia: a review. Korean Circ J. 2018;48(9):778–91.
doi: 10.4070/kcj.2018.0210
pubmed: 30088360
pmcid: 6110707
Aryana A, d’Avila A. Epicardial catheter ablation of ventricular tachycardia. Card Electrophysiol Clin. 2017;9(1):119–31.
doi: 10.1016/j.ccep.2016.10.009
pubmed: 28167080
Ploenes T, Aigner C. Giant pneumopericardium. Ann Thorac Surg. 2019;107(2):e145.
doi: 10.1016/j.athoracsur.2018.07.068
pubmed: 30266615
Juárez-Lloclla JP, León-Jiménez F, Urquiaga-Calderón J, Temoche-Nizama H, Bryce-Alberti M, Portmann-Baracco A, et al. Spontaneous pneumopericardium and pneumomediastinum in twelve covid-19 patients. Arch Bronconeumol. 2021;57(Suppl):186–8.
Beom JW, Ko Y, Boo KY, Lee JG, Choi JH, Joo SJ, et al. A successfully treated case of primary purulent pericarditis complicated by cardiac tamponade and pneumopericardium. Acute Crit Care. 2021;36(1):70–4.
doi: 10.4266/acc.2020.00234
pubmed: 33040519
Bansal R, Mahajan A, Rathi C, Lokhandwala Y. Pneumothorax leading to pneumopericardium after transvenous lead implantation in a patient with previous epicardial lead. Pacing Clin Electrophysiol. 2021;44(3):545–7.
doi: 10.1111/pace.14136
pubmed: 33283283
Nazir A, Egred M. Pneumopericardium. Eur Heart J. 2021;42(14):1445.
doi: 10.1093/eurheartj/ehaa692
pubmed: 33159791
Okubo K, Trevisi N, Foppoli L, Bisceglia C, Baratto F, Gigli L, et al. Phrenic nerve limitation during epicardial catheter ablation of ventricular tachycardia. JACC Clin Electrophysiol. 2019;5(1):81–90.
doi: 10.1016/j.jacep.2018.08.011
pubmed: 30678790
Pelargonio G, Casella M, Russo AD, Natale A. Entrapped air and normal saline in the pericardium after epicardial ablation. Heart Rhythm. 2009;6(10):1536–7.
doi: 10.1016/j.hrthm.2008.12.012
pubmed: 19628437